The Neurovascular Thrombectomy Devices Market is slated to grow on a stellar note going forward. The current situation is that digitization, which has the capacity of changing the dynamics of any vertical, has made a beeline to the healthcare vertical. The world out there no more depends on references for choosing healthcare services but goes for 360-degree research before arriving at the final decision. This would be the digitized healthcare vertical in the future.
The latest research report by Persistence Market Research (PMR), a well-known name in market research, states that the Neurovascular Thrombectomy Devices Market will witness a CAGR of 6.40% from 2022 to 2026, and will exceed USD 841.2 million in the market value by the end of 2026. The growing incidence of ischemic stroke is projected to boost the growth of the Global Neurovascular Thrombectomy Devices Market.
As per the Centers for Disease Control and Prevention (CDC) in the United States, ischemic strokes account for almost 87% of all the strokes and are a primary cause of long-term impairment. It is anticipated that such stroke occurrences would increase in the years to come. This factor is expected to drive the growth of the Global Neurovascular Thrombectomy Devices Market.
How About Looking Through The Sample Of Neurovascular Thrombectomy Devices Market Report? https://www.persistencemarketresearch.com/samples/26176
Company Profiles:
- Medtronic Plc
- Stryker Corporation
- Teleflex Incorporated
- Terumo Corporation
- Johnson & Johnson Services, Inc.
- Penumbra Inc.
- Boston Scientific Corporation
- Edwards Lifesciences Corporation
- Acandis GmbH
- Argon Medical Inc
How About Step-By-Step Insights To Neurovascular Thrombectomy Devices Market? Look Through The “Methodology” Employed! https://www.persistencemarketresearch.com/methodology/26176
The Impact of COVID-19 on the Neurovascular Thrombectomy Devices Market
Even though the COVID-19 has affected various healthcare operations, the Neurovascular Thrombectomy Devices Market has grown rapidly. The increased risk of thromboembolism among COVID-19 patients drove up demand for thrombectomy treatments, increasing market revenue.
North America is projected to have a sizable market share
The increasing prevalence of acute ischemic strokes, extensive research, enhanced product launches, and rising strategic initiatives by leading market players are the primary driving factors for the growth of the North American Neurovascular Thrombectomy Devices Market. Because of the high prevalence of stroke, the U.S. is likely to occupy a considerable proportion of the market over the forecast period. Furthermore, increased investments will enhance market innovation, consequently boosting the market growth.
In addition, rising Asia-Pacific countries such as China and India are likely to emerge as new revenue-generating markets. The existence of a large patient pool for target illnesses increased awareness among surgeons about the advantages of Neurovascular Thrombectomy Devices, increased healthcare expenditure, and increased use of these devices, all contribute to the growth of this Asia-Pacific’s market.
Want More Insights?
PMR has presented a comprehensive report based on Neurovascular Thrombectomy Devices Market as per Product Type (Stent Retriever and Aspiration Catheter), End User (Hospitals, Neuro-Catheterization Labs and Specialized Neurosurgery Centers) based on seven regions.
Want To Keep A Tab On The Latest Findings In The Neurovascular Thrombectomy Devices Market? Purchase Our Neurovascular Thrombectomy Devices Market Report Now! https://www.persistencemarketresearch.com/checkout/26176
About Us: Persistence Market Research
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com